ability to retard not only APD shortening in metabolically may be accounted for by differences in subunit compoinhibited ventricular myocytes but also loss of excitability of hippocampal CA1 neurons under metabolic inhibition.
Results subsequently treated with PMA or PMA plus chelerythrine for 30 min at 37ЊC, then fixed, permeabilized, and labeled with fluorescent secondary antibodies at PMA Causes a Reduction of Surface K ATP Channels in Xenopus Oocytes and COS-7 Cells room temperature. Most of the labeled channels appeared to have remained on the plasma membrane if Exposing oocytes expressing Kir6.2 and SUR1/2A to the metabolic inhibitor sodium azide (3 mM) for 10 min cells were not exposed to PMA. In contrast, significant endocytosis of K ATP channels followed the PMA treatinduced the K ATP current, with a somewhat variable time course of onset. This azide-induced current was signifiment, as indicated by the shift of antibody-labeled channels from the plasma membrane to numerous endocytic cantly reduced by 100 nM PMA pretreatment ( Figure  1A ). This K ATP downregulation was evident when cells vesicles inside the cell ( Figure 1C ). The PKC inhibitor chelerythrine prevented PMA from causing channel inwere exposed to PMA (100 nM) for 15 min ( Figure Figure 3A ). By contrast, there was relatively minor overlap between internalized channels panel) (53.2% Ϯ 5.4% for Kir6.2 and SUR1 and 49.1% Ϯ 4.3% for Kir6.2 and SUR2A, n ϭ 7, p Ͻ 0.01 versus and the default recycling pathway marked by Rme1 (G429R) ( Figure 3A ). control). No reduction was observed when cells were exposed to PMA together with the PKC inhibitor cheleTo further explore the mechanism for PKC-induced channel endocytosis, we tested the effect of expressing rythrine (10 M) ( Figure 1B , lower left panel; n ϭ 6). The inactive congener 4␣-PDD (100 nM) also had no effect the dominant-negative mutant dynamin 1 (K44E). Disruption of dynamin function blocked PKC downregula-( Figure 1B , lower left panel; n ϭ 7). These results indicate that the PKC downregulation of channel activity could tion of K ATP channels on the COS-7 cell surface ( Figure  3B , left panel; p Ͻ 0.01 versus PMA alone, n ϭ 6) and be accounted for by a 2-fold reduction in the number of channels on the cell membrane.
prevented PKC from reducing K ATP current in metabolically inhibited oocytes ( Figure 3B, Figure 4B , left panel; 104.5% Ϯ 6.3%, n ϭ suggesting that the dileucine motif plays a role in constitutive channel endocytosis. Interestingly, these mutant 7). In contrast, alanine substitution of LRKR in Kir6.2 (Kir6.2C4A) yielded tetrameric channels that were downchannels no longer responded to PMA treatment with a decrease in cell surface expression ( Figure 4B , right regulated by the PMA treatment ( Figure 4B, left ( Figure 4C ). Moreover, PMA treatment of COS-7 cells failed to induce internalization of K ATP channels lacking A dileucine motif is located within the last 36 amino Figure 6B ). Consesame amino acid composition, S10. The D10 or S10 peptide was added to the solution in the patch clamp quently, whereas cardiac K ATP channel activation causes action potentials to shorten during ischemia or metaelectrode and allowed to diffuse into the cardiac myocyte under whole-cell patch clamp for 20 min before bolic inhibition (Nichols and Lederer, 1991; Wilde, 1993), PMA pretreatment reduced action potential shortening these myocytes were treated with PMA for 30 min. There were no significant alterations in APD 90 after dialyzing of myocytes exposed to glucose-free solutions containing the metabolic inhibitors cyanide (2 mM) and peptides into the myocytes or after the subsequent PMA treatment for 30 min ( Figure 6D , top panel). Thus, these 2-deoxy-glucose (10 mM) ( Figure 6C ; n ϭ 7). The 30 min PMA pretreatment did not affect the resting membrane treatments had no detectable effects on cardiac channels other than K ATP channels, which remained quiescent potential (Ϫ83.5 Ϯ 5.3 mV, n ϭ 21) nor the shape or duration of action potentials prior to metabolic inhibition in healthy myocytes. Eight minutes of metabolic inhibition caused more severe reduction of APD 90 in PMA-(MI) (data not shown). Thus, whereas PKC pretreatment does not appear to affect channels that are active in treated cells dialyzed with D10, compared to PMAtreated cells dialyzed with S10 ( Figure 6D ; 13.8 Ϯ 1.4 healthy myocytes, it reduces the extent of endogenous K ATP channel activation during metabolic stress. ms for D10 group versus 32.8 Ϯ 2.4 ms for S10 group, p Ͻ 0.01, n ϭ 8). Therefore, the effect of PKC on APD To test whether PKC downregulates endogenous K ATP channels by promoting internalization, we examined the shortening is dynamin dependent. 
PMA (100 nM) pretreatment partially blocks the reduction of AP firing frequency in metabolically inhibited neurons containing S10 (left) but not in metabolically inhibited neurons containing the dominant-negative dynamin peptide D10 (100 M, right). (C) Metabolic inhibition (MI)-induced wholecell currents recorded at

